Abstract
The complement system, one of the first lines of defense of the innate immunity, is an important mechanism by which the body recognizes foreign substances and pathogens. This system consists of over 35 proteins, among them regulators and membrane-bound receptors and plasma proteins that interact with multiple cells and mediators of the immune system. These interactions vary according to the pathophysiologic context and occur at different stages of the immune reaction. Snake venoms contain potent cocktails of proteolytic enzymes, and the possibilities of these enzymes to interact with the complement system by either activating it or inhibiting have been investigated in many studies. The activation of the complement system by snake venoms, by generation of the potent anaphylatoxin C5a, could help the spread of the other toxic components and thereby enhancing the immobilization of the prey. Discovery of snake components that interact with the complement system may elucidate more about how the venom of snakes is spread in their prey, as well as the role of this interaction on the pathogenesis of the envenomations. It may also lead to discovery of components that aids the studies of the roles of complement in health and disease and also may yield novel anticomplement therapeutic agents. This review summarizes the key contributions regarding the action of snake venom toxins on the complement system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ayres LR, Récio Ados R, Burin SM, Pereira JC, Martins AC, Sampaio SV, de Castro FA, Pereira-Crott LS. Bothrops snake venoms and their isolated toxins, an L-amino acid oxidase and a serine protease, modulate human complement system pathways. J Venom Anim Toxins Incl Trop Dis. 2015;21:29.
Bajic G, Degn SE, Thiel S, Andersen GR. Complement activation, regulation, and molecular basis for complement-related diseases. EMBO J. 2015;34:2735–57.
Ballow M, Cochrane CG. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them. J Immunol. 1969;103:944–52.
de Cordoba SR, Tortajada A, Harris CL, Morgan BP. Complement dysregulation and disease: from genes and proteins to diagnostics and drugs. Immunobiology. 2012;217:1034–46.
Farsky SH, Walber J, Costa-Cruz M, Cury Y, Teixeira CF, Curry Y. Leukocyte response induced by Bothrops jararaca crude venom: in vivo and in vitro studies. Toxicon. 1997;35:185–93.
Farsky SH, Gonçalves LR, Gutiérrez JM, Correa AP, Rucavado A, Gasque P, Tambourgi DV. Bothrops asper snake venom and its metalloproteinase BaP-1 activate the complement system. Role in leucocyte recruitment. Mediat Inflamm. 2000;9:213–21.
Klos A, Tenner AJ, Johswich KO, Ager RR, Reis ES, Köhl J. The role of the anaphylatoxins in health and disease. Mol Immunol. 2009;46:2753–66.
Lin X, Qi JZ, Chen MH, Qiu BT, Huang ZH, Qiu PX, Chen JS, Yan GM. A novel recombinant fibrinogenase of Agkistrodon acutus venom protects against hyperacute rejection via degradation of complements. Biochem Pharmacol. 2013;85:772–9.
Menaldo DL, Bernardes CP, Pereira JC, Silveira DS, Mamede CC, Stanziola L, Oliveira F, Pereira-Crott LS, Faccioli LH, Sampaio SV. Effects of two serine proteases from Bothrops pirajai snake venom on the complement system and the inflammatory response. Int Immunopharmacol. 2013;15:764–71.
Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT. Complement system part I – molecular mechanisms of activation and regulation. Front Immunol. 2015;6:262.
Minta JO, Man DP, Wasi S, Painter RH. Interaction of Crotalus atrox venom with serum complement: kinetic analysis. Immunochemistry. 1977;14:513–9.
Müller-Eberhard HJ. Molecular organization and function of the complement system. Annu Rev Biochem. 1988;57:321–47.
O’Keefe MC, Caporale LH, Vogel CW. A novel cleavage product of human complement component C3 with structural and functional properties of cobra venom factor. J Biol Chem. 1988;263:12690–7.
Pidde-Queiroz G, Furtado MEF, Filgueiras CF, Pessoa LA, Spadafora-Ferreira M, van den Berg CW, Tambourgi DV. Human complement activation and anaphylatoxins generation induced by snake venom toxins from Bothrops genus. Mol Immunol. 2010;47:2537–44.
Pidde-Queiroz G, Magnoli FC, Portaro FC, Serrano SM, Lopes AS, Paes Leme AF, van den Berg CW, Tambourgi DV. P-I snake venom metalloproteinase is able to activate the complement system by direct cleavage of central components of the cascade. PLoS Negl Trop Dis. 2013;7:e2519.
Rael ED, Jones LP. Isolation of an anticomplement factor from the venom of the Mojave rattlesnake (Crotalus scutulatus scutulatus). Toxicon. 1983;21:57–65.
Rehana S, Manjunatha Kini R. Molecular isoforms of cobra venom factor-like proteins in the venom of Austrelaps superbus. Toxicon. 2007;50:32–52.
Rodrigues FG, Petretski JH, Kanashiro MM, Lemos L, da Silva WD, Kipnis TL. The complement system is involved in acute inflammation but not in the hemorrhage produced by a Bothrops atrox snake venom low molecular mass proteinase. Mol Immunol. 2004;40:1149–56.
Shoibonov BB, Osipov AV, Kryukova EV, Zinchenko AA, Lakhtin VM, Tsetlin VI, Utkin YN. Oxiagin from the Naja oxiana cobra venom is the first reprolysin inhibiting the classical pathway of complement. Mol Immunol. 2005;42:1141–53.
Stone SF, Isbister GK, Shahmy S, Mohamed F, Abeysinghe C, Karunathilake H, Ariaratnam A, Jacoby-Alner TE, Cotterell CL, Brown SG. Immune response to snake envenoming and treatment with antivenom; complement activation, cytokine production and mast cell degranulation. PLoS Negl Trop Dis. 2013;7:e2326.
Sun QY, Bao J. Purification, cloning and characterization of a metalloproteinase from Naja atra venom. Toxicon. 2010;56(8):1459–69.
Tambourgi DV, dos Santos MC, de Furtado MF, de Freitas MC, da Silva WD, Kipnis TL. Pro-inflammatory activities in elapid snake venoms. Br J Pharmacol. 1994;112:723–7.
Tanaka GD, Pidde-Queiroz G, de Fátima D, Furtado M, van den Berg C, Tambourgi DV. Micrurus snake venoms activate human complement system and generate anaphylatoxins. BMC Immunol. 2012;13:4.
van den Berg CW, Aerts PC, Van Dijk H. In vivo anti-complementary activities of the cobra venom factors from Naja naja and Naja haje. J Immunol Methods. 1991;136:287–94.
Vogel CW, Fritzinger DC. Cobra venom factor: structure, function, and humanization for therapeutic complement depletion. Toxicon. 2010;56:1198–222.
Vogel CW, Finnegan PW, Fritzinger DC. Humanized cobra venom factor: structure, activity, and therapeutic efficacy in preclinical disease models. Mol Immunol. 2014;61:191–203.
von Zabern I, Przyklenk H, Damerau B, Zimmermann B. Isolation and properties of a complement inhibitor from Naja haje venom, distinct from known anticomplementary factors in cobra venom. Scand J Immunol. 1981;14:109–20.
Yamamoto C, Tsuru D, Oda-Ueda N, Ohno M, Hattori S, Kim ST. Trimeresurus flavoviridis (habu snake) venom induces human erythrocyte lysis through enzymatic lipolysis, complement activation and decreased membrane expression of CD55 and CD59. Pharmacol Toxicol. 2001;89:188–94.
Yamamoto C, Tsuru D, Oda-Ueda N, Ohno M, Hattori S, Kim ST. Flavoxobin, a serine protease from Trimeresurus flavoviridis (habu snake) venom, independently cleaves Arg726-Ser727 of human C3 and acts as a novel, heterologous C3 convertase. Immunology. 2002;107:111–7.
Zeng L, Sun QY, Jin Y, Zhang Y, Lee WH. Molecular cloning and characterization of a complement-depleting factor from king cobra, Ophiophagus hannah. Toxicon. 2012;60:290–301.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Tambourgi, D.V., van den Berg, C.W. (2017). Non-Cobra Venom Factor Venom Components Acting on Complement Proteins. In: Inagaki, H., Vogel, CW., Mukherjee, A., Rahmy, T. (eds) Snake Venoms. Toxinology. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6410-1_30
Download citation
DOI: https://doi.org/10.1007/978-94-007-6410-1_30
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6409-5
Online ISBN: 978-94-007-6410-1
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences